Anxiety & GAD
Overview
Anxiety and General Anxiety Disorder (GAD) share overlapping biological dysfunctions with other neurocognitive conditions, notably chronic inflammation, neurochemical imbalance, mitochondrial impairment, oxidative stress, impaired methylation, gut–brain axis disruption, and glucose dysregulation (see Mohamed and Kobeissy 2024). Nutritional strategies that stabilize glycemia, fortify the gut–brain axis, and modulate neurotransmission—such as prebiotic fibers and vagus-supportive probiotics—demonstrate anxiolytic potential (see Johnstone et al. 2021; Bravo et al. 2011).
Biological Target Matrix
No biological targets found for therapeutic area: Anxiety & GAD